Why the study?
Does stent implantation reduce MACCE risks in acute STEMI patients with single vessel intermediate stenosis culprit lesions compared to non-stenting treatment?
Does stent implantation reduce MACCE risks in acute STEMI patients with single vessel intermediate stenosis culprit lesions compared to non-stenting treatment?
Stent implantation for single vessel intermediate stenosis culprit lesions in acute STEMI reduces MACCE risks at 12 months compared to non-stenting.
Stenting improves outcomes in STEMI with intermediate culprit lesions; extends RCT evidence to this population.
BACKGROUND: The benefit/risk ratio of stenting in acute ST-segment elevation myocardial infarction (STEMI) patients with single vessel intermediate stenosis culprit lesions merits further study, therefore the subject of the present study. METHODS AND RESULTS: = 0.03). The two groups shared similar cardiac death, repeat revascularization, stroke, all cause death, ischemia driven readmission and bleeding rates at 12 months. CONCLUSIONS: Stent implantation had better efficacy and safety in reducing MACCE risks among acute STEMI patients with single vessel intermediate stenosis culprit lesions.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: